Triamcinolone acetonide injection combined with Thera-band training on subacromial bursitis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800020421

Enrollment

Unknown

Registered

2018-12-29

Start date

2015-01-01

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subacromial bursitis

Interventions

TA group:triamcinolone acetonide (TA) injection

TA+TB group:triamcinolone acetonide (TA) injection combined with strength- training by via Thera-band EBs

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1) first- time diagnosis; 2) history of overhead activity for >2 months; 3) shoulder pain and range of motionROM limitation for at least >1 month.

Exclusion criteria

Exclusion criteria: 1) analgesic medication, physical therapy, or previous injection; 2) history of shoulder traumatic history; 3) rotator cuff tear, subacromial impingement syndrome, tendinitis of the long head of the biceps brachii, and frozen shoulder; 4) Diabetesdiabetes, cardio-cerebrovascular disease, and history of mental disorders; 5) concomitant immune inflammatory disease, such as rheumatoid arthritis, systemic lupus erythematosus, or ankylosing spondylitis.

Design outcomes

Primary

Measure	Time frame
Constant;VAS;	—

Secondary

Measure	Time frame
ROM;proprioception;Isometric muscle strength;	—

Countries

China

Contacts

Public ContactCAI YU

Wuhan Fourth Hospita

caiy_kf@163.com+86 18702745799

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026